ShareValue scores for PTG.WAR: Valuation 48, Quality 44, Growth 55, Health 52.
PTG.WARGPW
PolTREG S.A.
PLN 19.00
(+1.33%)
PTG.WARGPW
PolTREG S.A.
PLN 19.00(+1.33%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 17%
Rating
Trap Risk
Return
6% to 17%
Valuation
48
Fair Value
Price vs Value
Quality
44
Moderate
Business Strength
Growth
55
Moderate
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
46
Neutral
Price Trend
Company Details
About
Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.
Market Cap$103M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1329
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026